Finance

Lists
Why is RPGLIFE up 4,74%?
Dive Deeper
RPGLIFE:NSE
RPG Life Sciences Ltd
2 848,00 ₹
+4,74%
(+128,80) 1D
12 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
2 705,10 ₹
High
2 894,90 ₹
Low
2 705,10 ₹
Mkt. cap
47,10 մլրդ
Avg. vol.
33,03 հզր
Volume
29,77 հզր
Dividend
0,84%
Quarterly dividend
6,00 ₹
Ex-dividend date
09 հլս, 2026 թ.
P/E ratio
39,37
52-wk high
3 127,80 ₹
52-wk low
1 733,00 ₹
EPS
72,34 ₹
Shares outstanding
16,54 մլն
No. of employees
1 հզր
Open
2 705,10 ₹
High
2 894,90 ₹
Low
2 705,10 ₹
Mkt. cap
47,10 մլրդ
Avg. vol.
33,03 հզր
Volume
29,77 հզր
Dividend
0,84%
Quarterly dividend
6,00 ₹
Ex-dividend date
09 հլս, 2026 թ.
P/E ratio
39,37
52-wk high
3 127,80 ₹
52-wk low
1 733,00 ₹
EPS
72,34 ₹
Shares outstanding
16,54 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1,37 հզր
Founded1993
Headquarters-
Sector-
Last report
28 հլս, 2026 թ.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,96 մլրդ / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,82 մլրդ
1,80 մլրդ
1,77 մլրդ
1,96 մլրդ
Cost of goods sold
665,80 մլն
649,00 մլն
661,00 մլն
681,50 մլն
Cost of revenue
665,80 մլն
649,00 մլն
661,00 մլն
681,50 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
361,60 մլն
353,20 մլն
570,90 մլն
377,60 մլն
Operating expense
812,90 մլն
807,50 մլն
835,00 մլն
901,50 մլն
Total operating expenses
1,48 մլրդ
1,46 մլրդ
1,50 մլրդ
1,58 մլրդ
Operating income
338,10 մլն
343,80 մլն
273,30 մլն
373,90 մլն
Other non operating income
45,40 մլն
34,10 մլն
-101,90 մլն
47,00 մլն
EBT including unusual items
494,50 մլն
291,20 մլն
402,00 մլն
414,60 մլն
EBT excluding unusual items
382,30 մլն
375,40 մլն
277,30 մլն
414,60 մլն
Income tax expense
126,00 մլն
69,90 մլն
103,00 մլն
107,00 մլն
Effective tax rate
25,48%
24,00%
25,62%
25,81%
Other operating expenses
399,10 մլն
400,50 մլն
206,70 մլն
464,90 մլն
Net income
368,50 մլն
221,30 մլն
299,00 մլն
307,60 մլն
Net profit margin
20,28%
12,29%
16,90%
15,72%
Earnings per share
-
-
-
-
Interest and investment income
-
-
96,70 մլն
-
Interest expense
-1,20 մլն
-2,50 մլն
-3,90 մլն
-6,30 մլն
Net interest expenses
-1,20 մլն
-2,50 մլն
92,80 մլն
-6,30 մլն
Depreciation and amortization charges
52,20 մլն
53,80 մլն
57,40 մլն
59,00 մլն
EBITDA
389,90 մլն
395,75 մլն
325,80 մլն
426,40 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps